Artificial Intelligence raises both hope and fears in all areas and particularly in health. Hope because it proposes to address problems that have so far been left unresolved. Fears not only because it is a subject that is not very easy to grasp (the general public does not really know how it works) but also because it can decide for humans, in an arbitrary way.
And when it comes to the patient’s free will, an essential dimension appears: Ethics Free will and dignity are key to the patient, in the face of the medical world and disease. AI makes these needs even more essential because they are a great help in healing.
The round table “Putting power back into the hands of patients” of the European AI for Health conference (Paris September 5, 2019) presented 3 startups at the heart of this topic whose philosophy consists in co-defining solutions with patients in healing management.
1/ Hillo builds a simple and comprehensive tool treatment decision for patients with diabetes. The startup reduces dosage errors by rationally monitoring all parameters related to the patient’s blood glucose level. It gives him a decision-making tool that indicates the right treatment to be administered. Stéphane Bidet, CEO & Co-founder, is now entering a crucial phase of its development through a test partnership with hospitals.
2/ Synapse delivers scientific and medical accurate information through an AI-platform powered by Google Assistant to prevent errors in prescriptions. The tool is based on the interactions between the patient and the doctor during the consultation and adapts the right prescription to the real need. The machine learning process is fed with the help of patients who send photos of prescriptions and the feedback from doctors and pharmacists. Dr Clément Goehrs, CEO de Synapse has signed a partnership with the French Health Insurance.
3/ ExactCure simulate effects of drugs according to the characteristics of the patients : gender, age, constitution, etc…Patients can use an app to avoid over or under dose, bad interactions between other drugs. It addresses chronical diseases such as neurodegenerative, belly, cardio vascular ones. AxactCure and works in partnership with researchers, doctors, pharmacists to model qualitative feedback. It aims at a step by step -go to market
These 3 startups show that a fairer and more ethical treatment requires large-scale cooperation with the patient himself , who becomes an actor in his healing journey.
By Dominique Hadria